Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance
Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagn...
Saved in:
Published in | Diabetology and metabolic syndrome Vol. 7; no. 1; p. 33 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
10.04.2015
BioMed Central Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 1758-5996 1758-5996 |
DOI | 10.1186/s13098-015-0029-0 |
Cover
Loading…
Abstract | Background
Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471).
Methods
Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects.
Results
The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of β-cell insulin secretion (HOMA-β) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels.
Conclusion
CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension. |
---|---|
AbstractList | Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Methods Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. Results The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of [beta]-cell insulin secretion (HOMA-[beta]) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. Conclusion CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension. Keywords: C1q/TNF-related protein-3, Insulin resistance, Obesity, Essential hypertension Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Methods Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. Results The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of β-cell insulin secretion (HOMA-β) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. Conclusion CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension. Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of [beta]-cell insulin secretion (HOMA-[beta]) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension. BACKGROUNDInsulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471).METHODSSerum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects.RESULTSThe serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of β-cell insulin secretion (HOMA-β) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels.CONCLUSIONCTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension. Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of β-cell insulin secretion (HOMA-β) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension. |
ArticleNumber | 33 |
Audience | Academic |
Author | Li, Changyan Tian, Mingyuan Chen, Bing Zhang, Yuping Li, Ling Deng, Wuquan Yang, Gangyi Yang, Mengliu Zhao, Jie Zheng, Yanling |
Author_xml | – sequence: 1 givenname: Wuquan surname: Deng fullname: Deng, Wuquan organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University – sequence: 2 givenname: Changyan surname: Li fullname: Li, Changyan organization: Department of Nephropathy, Chengdu Fifth Pepole’s Hospital – sequence: 3 givenname: Yuping surname: Zhang fullname: Zhang, Yuping organization: Department of Endocrinology, Southwest Hospital, Third Military Medical University – sequence: 4 givenname: Jie surname: Zhao fullname: Zhao, Jie organization: Department of Endocrinology, Southwest Hospital, Third Military Medical University – sequence: 5 givenname: Mengliu surname: Yang fullname: Yang, Mengliu organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University – sequence: 6 givenname: Mingyuan surname: Tian fullname: Tian, Mingyuan organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University – sequence: 7 givenname: Ling surname: Li fullname: Li, Ling organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University – sequence: 8 givenname: Yanling surname: Zheng fullname: Zheng, Yanling organization: Department of Endocrinology, Southwest Hospital, Third Military Medical University – sequence: 9 givenname: Bing surname: Chen fullname: Chen, Bing organization: Department of Endocrinology, Southwest Hospital, Third Military Medical University – sequence: 10 givenname: Gangyi surname: Yang fullname: Yang, Gangyi email: dwq_cq@126.com organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25878729$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kt2K1DAYhousuD96AZ5IQJD1oLtJ0zTNibAMrgqLio7HIU2_zmRJk9kkXZl78WLNODsyI7L0ICV53qf9yHtaHDnvoCheEnxBSNtcRkKxaEtMWIlxJUr8pDghnLUlE6I52ns_Lk5jvMW44YzXz4rjirW85ZU4KX59hzCNaEbuLuefr8sAViXo0Sr4BMaVFJ3P5t--0rfIwj3YiFQA1IMOoGLGjEO-g2jSGinXo-V6BSGBi8a7Pxsb2sFCJZPDa6R92H3gp0lLtFJBjZAgROSHLIuTzcaQhTEpp-F58XRQNsKLh_Ws-HH9fj77WN58-fBpdnVTalbjVHbA25aBUoOgSmhOO8KI7rtKE9oT1igMgOueCsFa3YDoakLz9KqqGgUd0_SseLf1rqZuhF6DS0FZuQpmVGEtvTLy8MSZpVz4e1lTwXnVZMH5gyD4uwlikqOJGqxVDvwUJWl4XWGCKcno6y26UBakcYPPRr3B5RWrSVNhTutMXfyHyk8Po9G5BYPJ-weBN3uBJSibltHbKeWriIfgq_1Z_w65q0QG-BbQwccYYJDaJLXx5F8wVhIsN-WT2_LJXD65KZ_EOUn-Se7kj2WqbSZm1i0gyFs_BZdv-5HQb2217Hs |
CitedBy_id | crossref_primary_10_1530_REP_17_0783 crossref_primary_10_3390_diagnostics9020063 crossref_primary_10_1016_j_dsx_2018_10_004 crossref_primary_10_1186_s13098_015_0099_z crossref_primary_10_1152_ajpregu_00212_2017 crossref_primary_10_1002_btm2_10150 crossref_primary_10_1016_j_cca_2015_11_031 crossref_primary_10_1152_ajpendo_00248_2015 crossref_primary_10_1016_j_plipres_2016_10_001 crossref_primary_10_1016_j_ceca_2017_06_009 crossref_primary_10_1016_j_tcm_2022_12_004 crossref_primary_10_1002_iub_2293 crossref_primary_10_1016_j_dsx_2019_04_047 crossref_primary_10_7717_peerj_2573 crossref_primary_10_1371_journal_pone_0168773 crossref_primary_10_1016_j_amjcard_2018_06_024 crossref_primary_10_3390_cells10082146 crossref_primary_10_3389_fimmu_2022_1002616 crossref_primary_10_3390_nu15061482 crossref_primary_10_1042_CS20180179 crossref_primary_10_1097_NNR_0000000000000319 crossref_primary_10_3390_metabo14120672 crossref_primary_10_1080_0886022X_2018_1561373 crossref_primary_10_1007_s42000_024_00592_5 crossref_primary_10_1016_j_cyto_2017_10_023 crossref_primary_10_5812_ijem_74250 crossref_primary_10_1186_s41231_021_00083_4 crossref_primary_10_1515_tjb_2022_0237 crossref_primary_10_1016_j_bbagen_2016_10_022 crossref_primary_10_1016_j_nefro_2022_02_002 crossref_primary_10_1186_s12950_018_0185_8 crossref_primary_10_1155_2020_8873152 crossref_primary_10_17826_cumj_735270 crossref_primary_10_3389_fendo_2022_873699 crossref_primary_10_1016_j_cca_2018_01_003 crossref_primary_10_29252_rbmb_9_1_71 crossref_primary_10_3390_ijms21218168 crossref_primary_10_1007_s11695_018_3306_9 crossref_primary_10_1097_HJH_0000000000003591 crossref_primary_10_14814_phy2_12735 crossref_primary_10_1186_s12872_019_1117_0 crossref_primary_10_1016_j_jcmgh_2022_12_013 crossref_primary_10_1615_CritRevImmunol_2024051292 crossref_primary_10_1002_cbin_10674 crossref_primary_10_36660_abc_20200669 crossref_primary_10_3390_ijms23179988 crossref_primary_10_1016_j_nefroe_2022_02_009 crossref_primary_10_14814_phy2_14306 crossref_primary_10_1016_j_mce_2018_04_006 crossref_primary_10_1111_eci_12709 crossref_primary_10_3390_jcm8060805 crossref_primary_10_1007_s00109_024_02426_8 crossref_primary_10_1371_journal_pone_0241813 crossref_primary_10_1016_j_lfs_2020_117913 crossref_primary_10_1161_CIRCRESAHA_115_306885 crossref_primary_10_3389_fphys_2020_570270 crossref_primary_10_5812_ijp_74250 |
Cites_doi | 10.1007/BF00280883 10.1210/jc.2013-2227 10.1016/S0140-6736(14)60460-8 10.1186/1758-5996-6-72 10.1210/jc.2008-0253 10.2337/dc13-0178 10.1371/journal.pone.0055744 10.1016/j.beem.2013.01.004 10.1002/jcb.21190 10.1161/01.HYP.37.2.187 10.1161/01.CIR.98.14.1472 10.1161/CIRCULATIONAHA.112.099937 10.1016/j.cca.2013.02.003 10.1038/oby.2008.206 10.1186/1475-2840-13-14 10.1074/jbc.M007898200 10.1038/jhh.2011.58 10.1186/1475-2840-6-7 10.1042/BJ20082033 10.2337/diacare.27.12.2954 10.2337/diabetes.50.8.1943 10.1371/journal.pone.0112931 10.2337/db12-0217 10.1074/jbc.M110.180695 10.1016/j.tem.2011.12.003 10.1042/BJ20081240 10.1016/j.jjcc.2013.11.006 10.1017/S1368980008002802 10.1210/en.2010-0571 10.1042/CBI20090043 |
ContentType | Journal Article |
Copyright | Deng et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. COPYRIGHT 2015 BioMed Central Ltd. Deng et al.; licensee BioMed Central. 2015 |
Copyright_xml | – notice: Deng et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. – notice: COPYRIGHT 2015 BioMed Central Ltd. – notice: Deng et al.; licensee BioMed Central. 2015 |
DBID | C6C AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1186/s13098-015-0029-0 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1758-5996 |
EndPage | 33 |
ExternalDocumentID | PMC4397726 A541620734 25878729 10_1186_s13098_015_0029_0 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 53G 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU DIK E3Z EBD EBLON EBS EJD ESX FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RBZ RNS ROL RPM RSV SMD SOJ TUS U2A UKHRP AAYXX ALIPV CITATION -5E -5G -A0 -BR 2VQ 3V. ACRMQ ADINQ C24 IPNFZ NPM RIG PMFND 7X8 5PM |
ID | FETCH-LOGICAL-c540t-be7885eaaf93a9c73b151cdb2c13d156a0ee04d39958c6e9b413872a226aeb5c3 |
IEDL.DBID | M48 |
ISSN | 1758-5996 |
IngestDate | Thu Aug 21 18:10:23 EDT 2025 Fri Sep 05 04:54:47 EDT 2025 Tue Jun 17 22:05:10 EDT 2025 Tue Jun 10 21:04:52 EDT 2025 Thu May 22 21:24:07 EDT 2025 Thu Jan 02 22:22:16 EST 2025 Tue Jul 01 01:26:40 EDT 2025 Thu Apr 24 23:11:15 EDT 2025 Sat Sep 06 07:29:03 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | C1q/TNF-related protein-3 Obesity Essential hypertension Insulin resistance |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-be7885eaaf93a9c73b151cdb2c13d156a0ee04d39958c6e9b413872a226aeb5c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://link.springer.com/10.1186/s13098-015-0029-0 |
PMID | 25878729 |
PQID | 1674201031 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4397726 proquest_miscellaneous_1674201031 gale_infotracmisc_A541620734 gale_infotracacademiconefile_A541620734 gale_healthsolutions_A541620734 pubmed_primary_25878729 crossref_citationtrail_10_1186_s13098_015_0029_0 crossref_primary_10_1186_s13098_015_0029_0 springer_journals_10_1186_s13098_015_0029_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-04-10 |
PublicationDateYYYYMMDD | 2015-04-10 |
PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-10 day: 10 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Diabetology and metabolic syndrome |
PublicationTitleAbbrev | Diabetol Metab Syndr |
PublicationTitleAlternate | Diabetol Metab Syndr |
PublicationYear | 2015 |
Publisher | BioMed Central BioMed Central Ltd |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd |
References | P Primatesta (29_CR13) 2001; 37 B Wölfing (29_CR6) 2008; 16 T Maeda (29_CR16) 2001; 276 KM Choi (29_CR29) 2014; 13 K Nakamura (29_CR4) 2014; 63 DR Matthews (29_CR14) 1985; 28 A Kopp (29_CR5) 2010; 151 O Leal Vde (29_CR15) 2013; 419 T Maeda (29_CR30) 2010; 34 Z Mallat (29_CR11) 2009; 94 W Deng (29_CR25) 2014; 6 CP Wen (29_CR9) 2009; 12 RM Krauss (29_CR3) 1998; 98 M Ng (29_CR1) 2014; 384 B Ban (29_CR24) 2014; 9 HY Choi (29_CR19) 2013; 36 S Wurm (29_CR17) 2007; 6 AC Phillips (29_CR26) 2012; 26 MS Freiberg (29_CR12) 2004; 27 JM Li (29_CR27) 2007; 101 HJ Yoo (29_CR21) 2013; 8 W Yi (29_CR28) 2012; 125 KM Choi (29_CR18) 2012; 61 World Health Organization (29_CR10) 1999; 17 BK Tan (29_CR20) 2013; 98 T Shike (29_CR31) 2001; 50 M Chrostowska (29_CR2) 2013; 27 GW Wong (29_CR22) 2008; 416 KE Davis (29_CR8) 2008; 416 JM Peterson (29_CR23) 2010; 285 A Schäffler (29_CR7) 2012; 23 17171642 - J Cell Biochem. 2007 May 15;101(2):399-410 15562213 - Diabetes Care. 2004 Dec;27(12):2954-9 11071891 - J Biol Chem. 2001 Feb 2;276(5):3628-34 18854400 - J Clin Endocrinol Metab. 2009 Jan;94(1):255-60 17311679 - Cardiovasc Diabetol. 2007 Feb 20;6:7 11230269 - Hypertension. 2001 Feb;37(2):187-93 19947921 - Cell Biol Int. 2010 Jan 29;34(3):261-6 9760304 - Circulation. 1998 Oct 6;98(14):1472-6 18783346 - Biochem J. 2008 Dec 1;416(2):161-77 11473059 - Diabetes. 2001 Aug;50(8):1943-8 18990088 - Biochem J. 2008 Dec 1;416(2):e7-9 24932224 - Diabetol Metab Syndr. 2014 Jun 11;6:72 23731877 - Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):147-56 24152681 - J Clin Endocrinol Metab. 2013 Dec;98(12):E1891-900 3899825 - Diabetologia. 1985 Jul;28(7):412-9 24355497 - J Cardiol. 2014 Apr;63(4):250-9 23409033 - PLoS One. 2013;8(2):e55744 18421280 - Obesity (Silver Spring). 2008 Jul;16(7):1481-6 21654852 - J Hum Hypertens. 2012 Aug;26(8):485-92 22653084 - Circulation. 2012 Jun 26;125(25):3159-69 23780948 - Diabetes Care. 2013 Oct;36(10):3321-7 24880830 - Lancet. 2014 Aug 30;384(9945):766-81 20739398 - Endocrinology. 2010 Nov;151(11):5267-78 10067786 - J Hypertens. 1999 Feb;17(2):151-83 25409499 - PLoS One. 2014 Nov 19;9(11):e112931 22261190 - Trends Endocrinol Metab. 2012 Apr;23(4):194-204 23422739 - Clin Chim Acta. 2013 Apr 18;419:87-94 18547457 - Public Health Nutr. 2009 Apr;12(4):497-506 20952387 - J Biol Chem. 2010 Dec 17;285(51):39691-701 24417980 - Cardiovasc Diabetol. 2014 Jan 13;13:14 22837306 - Diabetes. 2012 Nov;61(11):2932-6 |
References_xml | – volume: 28 start-page: 412 year: 1985 ident: 29_CR14 publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 98 start-page: E1891 year: 2013 ident: 29_CR20 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-2227 – volume: 384 start-page: 766 year: 2014 ident: 29_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(14)60460-8 – volume: 6 start-page: 72 year: 2014 ident: 29_CR25 publication-title: Diabetol Metab Syndr doi: 10.1186/1758-5996-6-72 – volume: 94 start-page: 255 year: 2009 ident: 29_CR11 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0253 – volume: 36 start-page: 3321 year: 2013 ident: 29_CR19 publication-title: Diabetes Care doi: 10.2337/dc13-0178 – volume: 8 year: 2013 ident: 29_CR21 publication-title: PLoS One doi: 10.1371/journal.pone.0055744 – volume: 27 start-page: 147 year: 2013 ident: 29_CR2 publication-title: Best Pract Res Clin Endocrinol Metab doi: 10.1016/j.beem.2013.01.004 – volume: 101 start-page: 399 year: 2007 ident: 29_CR27 publication-title: J Cell Biochem doi: 10.1002/jcb.21190 – volume: 37 start-page: 187 year: 2001 ident: 29_CR13 publication-title: Hypertension doi: 10.1161/01.HYP.37.2.187 – volume: 98 start-page: 1472 year: 1998 ident: 29_CR3 publication-title: Circulation doi: 10.1161/01.CIR.98.14.1472 – volume: 125 start-page: 3159 year: 2012 ident: 29_CR28 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.099937 – volume: 419 start-page: 87 year: 2013 ident: 29_CR15 publication-title: Clin Chim Acta doi: 10.1016/j.cca.2013.02.003 – volume: 16 start-page: 1481 year: 2008 ident: 29_CR6 publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2008.206 – volume: 13 start-page: 14 year: 2014 ident: 29_CR29 publication-title: Cardiovasc Diabetol doi: 10.1186/1475-2840-13-14 – volume: 276 start-page: 3628 year: 2001 ident: 29_CR16 publication-title: J Biol Chem doi: 10.1074/jbc.M007898200 – volume: 26 start-page: 485 year: 2012 ident: 29_CR26 publication-title: J Hum Hypertens doi: 10.1038/jhh.2011.58 – volume: 6 start-page: 7 year: 2007 ident: 29_CR17 publication-title: Cardiovasc Diabetol doi: 10.1186/1475-2840-6-7 – volume: 416 start-page: e7 year: 2008 ident: 29_CR8 publication-title: Biochem J doi: 10.1042/BJ20082033 – volume: 27 start-page: 2954 year: 2004 ident: 29_CR12 publication-title: Diabetes Care doi: 10.2337/diacare.27.12.2954 – volume: 50 start-page: 1943 year: 2001 ident: 29_CR31 publication-title: Diabetes doi: 10.2337/diabetes.50.8.1943 – volume: 9 start-page: e112931 year: 2014 ident: 29_CR24 publication-title: PLoS One doi: 10.1371/journal.pone.0112931 – volume: 61 start-page: 2932 year: 2012 ident: 29_CR18 publication-title: Diabetes doi: 10.2337/db12-0217 – volume: 285 start-page: 39691 year: 2010 ident: 29_CR23 publication-title: J Biol Chem doi: 10.1074/jbc.M110.180695 – volume: 23 start-page: 194 year: 2012 ident: 29_CR7 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2011.12.003 – volume: 416 start-page: 161 year: 2008 ident: 29_CR22 publication-title: Biochem J doi: 10.1042/BJ20081240 – volume: 63 start-page: 250 year: 2014 ident: 29_CR4 publication-title: J Cardiol doi: 10.1016/j.jjcc.2013.11.006 – volume: 12 start-page: 497 year: 2009 ident: 29_CR9 publication-title: Public Health Nutr doi: 10.1017/S1368980008002802 – volume: 151 start-page: 5267 year: 2010 ident: 29_CR5 publication-title: Endocrinology doi: 10.1210/en.2010-0571 – volume: 34 start-page: 261 year: 2010 ident: 29_CR30 publication-title: Cell Biol Int doi: 10.1042/CBI20090043 – volume: 17 start-page: 151 year: 1999 ident: 29_CR10 publication-title: J Hypertens – reference: 24355497 - J Cardiol. 2014 Apr;63(4):250-9 – reference: 18854400 - J Clin Endocrinol Metab. 2009 Jan;94(1):255-60 – reference: 23422739 - Clin Chim Acta. 2013 Apr 18;419:87-94 – reference: 21654852 - J Hum Hypertens. 2012 Aug;26(8):485-92 – reference: 18783346 - Biochem J. 2008 Dec 1;416(2):161-77 – reference: 23409033 - PLoS One. 2013;8(2):e55744 – reference: 11230269 - Hypertension. 2001 Feb;37(2):187-93 – reference: 24932224 - Diabetol Metab Syndr. 2014 Jun 11;6:72 – reference: 18421280 - Obesity (Silver Spring). 2008 Jul;16(7):1481-6 – reference: 20739398 - Endocrinology. 2010 Nov;151(11):5267-78 – reference: 25409499 - PLoS One. 2014 Nov 19;9(11):e112931 – reference: 19947921 - Cell Biol Int. 2010 Jan 29;34(3):261-6 – reference: 18990088 - Biochem J. 2008 Dec 1;416(2):e7-9 – reference: 18547457 - Public Health Nutr. 2009 Apr;12(4):497-506 – reference: 22261190 - Trends Endocrinol Metab. 2012 Apr;23(4):194-204 – reference: 17311679 - Cardiovasc Diabetol. 2007 Feb 20;6:7 – reference: 23731877 - Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):147-56 – reference: 20952387 - J Biol Chem. 2010 Dec 17;285(51):39691-701 – reference: 22653084 - Circulation. 2012 Jun 26;125(25):3159-69 – reference: 22837306 - Diabetes. 2012 Nov;61(11):2932-6 – reference: 15562213 - Diabetes Care. 2004 Dec;27(12):2954-9 – reference: 24417980 - Cardiovasc Diabetol. 2014 Jan 13;13:14 – reference: 3899825 - Diabetologia. 1985 Jul;28(7):412-9 – reference: 11473059 - Diabetes. 2001 Aug;50(8):1943-8 – reference: 24880830 - Lancet. 2014 Aug 30;384(9945):766-81 – reference: 9760304 - Circulation. 1998 Oct 6;98(14):1472-6 – reference: 11071891 - J Biol Chem. 2001 Feb 2;276(5):3628-34 – reference: 24152681 - J Clin Endocrinol Metab. 2013 Dec;98(12):E1891-900 – reference: 10067786 - J Hypertens. 1999 Feb;17(2):151-83 – reference: 23780948 - Diabetes Care. 2013 Oct;36(10):3321-7 – reference: 17171642 - J Cell Biochem. 2007 May 15;101(2):399-410 |
SSID | ssj0067574 |
Score | 2.2972658 |
Snippet | Background
Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates... Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity... Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates... BACKGROUNDInsulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin... |
SourceID | pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 33 |
SubjectTerms | Analysis Blood sugar Development and progression Diabetes Endocrinology Genetic aspects Hypertension Insulin resistance Medical research Medicine Medicine & Public Health Medicine, Experimental Metabolic Diseases Obesity Risk factors |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFBajhbGXsXY3r12nwaC7IGrL8u0xhIUyaBklgb4JWVLWQCpvcfLQ_9If23NkOcxhG-zVOkLG5_Yd61wI-cAToUrwg0wBWmVCm5iVpraM6xwsMuDZPMcC54vL_Hwmvl1n16GOu-2z3fsrSW-pvVqX-VkL1hbLwZKM-ZwNiNP3MwjdURtnfNSbXwDAhQjXl3_cNnBAu2b4Nz-0myO5c1Hq_c_kGXkagCMddZw-II-sOySPL8LV-HNyD1q_uaXj5NfZ9HLCfI2KNdT3YVg4ltKP4-nV9_QTXWKaUEvVylLjMWMLZAtHm25EAFXO0BuITlc-t71x_gFSO_vDdwlf3lGNMz26A_BHLsUG4reYWNPSZk5DfjuFSB7RKYjVCzKbfJ2Oz1kYvcA0QLg1qy2ExplVal6lqtJFWgMy0KbmOkkNhHwqtjYWButiS-BqVYMvLAuuAMwpW2c6fUn2XOPsa0IB09h4Po-VEkYAndJ1bEWhEqOKoqySiMQ9P6QOfclxPMZS-vikzGXHQgkslMhCGUfk83bLz64px7-I3yGTZVdXulVoOcoAi3KwcCIip54CVRpO1ipUJsD7Y3OsAeXxgBJUUQ-W3_eCJHEJ89ecbTatxFoP7kdqRORVJ1jbN-dZCVaTVxEpBiK3JcAO4MMVt7jxncARTRY8j8iXXjhlMEHt3z_Im_-iPiJPuFceAR77mOytVxv7FnDYuj7xevcAP6gs6Q priority: 102 providerName: Springer Nature |
Title | Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance |
URI | https://link.springer.com/article/10.1186/s13098-015-0029-0 https://www.ncbi.nlm.nih.gov/pubmed/25878729 https://www.proquest.com/docview/1674201031 https://pubmed.ncbi.nlm.nih.gov/PMC4397726 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9NAFB7WXRBfxLvRtY4gCMq4yWRyexCpZesitIhsoW_DZGbqFroTt2nB_R_-YM-ZpMGUVXwJtHOapDm372TOhZDXPBIqBz_IFKBVJrQJWW5Ky7hOwSIDnk1TLHCeTNOzmfgyT-YHZDfeqn2A9Y2hHc6Tmq1X739eXX8Ehf_gFT5PT2qww1goFiXMZ3NABH8EjinFWGwiuk0FgMa-KTM4zJxhV5J2k_PGU_Tc1L6x_sNb7WdS7m2nei81vkfutvCSDht5uE8OrHtAbk_aDfSH5BfYhu0lHUVXJ-fTMfOVLNZQ361h6VhMV5hEVFO1ttR4RFnD8tLRqhkgQJUz9AJi17XPfK-c_wKpnf3ue4ivrqnGiR_NifE1L8X24peYdlPTakHb7HcKcT5iVxC6R2Q2Pj0fnbF2MAPTAPA2rLQQOCdWqUURq0JncQm4QZuS6yg2EBCq0NpQGKyazYHnRQmeMs-4AqinbJno-DE5dJWzTwkFxGPDxSJUShgBdEqXoRWZiozKsryIAhLu-CB127Uch2espI9e8lQ2rJPAOomsk2FA3nY_-dG07PgX8UtkrmyqTjt1l8MEBIiD_RMBeeMpUAThylq1dQtw_9g6q0d53KMERdW95Vc7AZK4hNltzlbbWmIlCPcDNwLypBGo7s55koNN5UVAsp6odQTYH7y_4pYXvk84Ys2MpwF5txNKudOvvz-QZ__9d5-TO9wrjABffkwON-utfQEIbVMOyK1sng3I0afT6ddv8GmUjgb-bQccP8-jgddLOM748DfPZD2r |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zj9MwELZQVwJeEPcGFtZISFyyNnGc67GqqErZVgi60r5Zju2ylboONO0D_4Ufy4yTVKQCJF7jsRxlrm_iOQh5ySOhcvCDTAFaZUKbkOWmtIzrFCwy4Nk0xQLn2TydXIjpZXLZ1nHXXbZ7dyXpLbVX6zw9q8HaYjlYlDCfswFx-lEOYEQMyNFwOP0y7QwwQOBMtBeYf9zYc0GHhvg3T3SYJXlwVeo90PguudNCRzpseH2P3LDuPrk5ay_HH5CfoPe7azqKvp8t5mPmq1Ssob4Tw8qxmL4eLT5_it_QNSYK1VRtLDUeNdZAtnK0aoYEUOUMvYL4dOOz2yvnHyC1s199n_D1D6pxqkdzAP7KpdhC_BpTa2paLWmb4U4hlkd8CoL1kFyM3y9GE9YOX2AaQNyWlRaC48QqtSxiVegsLgEbaFNyHcUGgj4VWhsKg5WxOfC1KMEb5hlXAOeULRMdPyIDVzl7TCigGhsul6FSwgigU7oMrchUZFSW5UUUkLDjh9RtZ3IckLGWPkLJU9mwUAILJbJQhgF5u9_yrWnL8S_iU2SybCpL9yothwmgUQ42TgTkladApYaTtWprE-D9sT1Wj_KkRwnKqHvLLzpBkriEGWzOVrtaYrUH90M1AvK4Eaz9m_MkB7vJi4BkPZHbE2AP8P6KW135XuCIJzOeBuRdJ5yyNUL13z_Ik_-iPiW3JovZuTz_MP_4lNzmXpEE-O8TMthudvYZoLJt-bzVwl-bDzEs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Za9wwEBYlgdCX0qSXm7RRodALsbYsX49h2yU9soSygbwJWZKbhY2crncf8l_6Yzsj20u8tIW-WmNsPNc3nouQ1zwSKgc_yBSgVSa0CVluSsu4TsEiA55NU2xwPpumpxfiy2Vy2e05bfpq9z4l2fY04JQmtxrdmKpV8TwdNWB5sTUsSpiv34CYfVeg58NsbTruTTGA4Ux0qcw_3jZwRtsm-Y5P2q6X3Eqael80eUgedCCSnrRc3yf3rDsge2ddmvwR-QUWYH1Nx9HP0Ww6Yb5fxRrqZzLMHYvp2_Hs-3n8ji6wZKihammp8fixAbK5o3W7LoAqZ-gVRKpLX-deO38BqZ394SeGL26pxv0e7QPwpy7FYeLXWGTT0LqiXa07hagekSqI2GNyMfk0G5-ybg0D0wDnVqy0ECYnVqmqiFWhs7gElKBNyXUUGwj_VGhtKAz2yObA4aIEv5hnXAGwU7ZMdPyE7Lja2WeEAr6xYVWFSgkjgE7pMrQiU5FRWZYXUUDCnh9SdzPKcVXGQvpYJU9ly0IJLJTIQhkG5P3mlpt2QMe_iI-RybLtMd0otzxJAJdysHYiIG88Bao3PFmrrksB3h8HZQ0ojwaUoJZ6cPyqFySJR1jL5my9biT2fXC_XiMgT1vB2rw5T3KwoLwISDYQuQ0BTgMfnrj5lZ8Kjsgy42lAPvTCKTtz1Pz9gzz_L-pjsnf-cSK_fZ5-PST3udcjAY78iOyslmv7AuDZqnzpVfA3SNM0Ag |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+C1q%2FTNF-related+protein-3+levels+are+decreased+in+obesity+and+hypertension+and+are+negatively+correlated+with+parameters+of+insulin+resistance&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Deng%2C+Wuquan&rft.au=Li%2C+Changyan&rft.au=Zhang%2C+Yuping&rft.au=Zhao%2C+Jie&rft.date=2015-04-10&rft.pub=BioMed+Central+Ltd&rft.issn=1758-5996&rft.eissn=1758-5996&rft.volume=7&rft_id=info:doi/10.1186%2Fs13098-015-0029-0&rft.externalDocID=A541620734 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon |